GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bedrocan Cannabis Corp (FRA:8BC) » Definitions » Debt-to-Revenue

Bedrocan Cannabis (FRA:8BC) Debt-to-Revenue : 1.13 (As of Apr. 2015)


View and export this data going back to . Start your Free Trial

What is Bedrocan Cannabis Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Bedrocan Cannabis's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Apr. 2015 was €0.10 Mil. Bedrocan Cannabis's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Apr. 2015 was €1.39 Mil. Bedrocan Cannabis's annualized Revenue for the quarter that ended in Apr. 2015 was €1.32 Mil. Bedrocan Cannabis's annualized Debt-to-Revenue for the quarter that ended in Apr. 2015 was 1.13.


Bedrocan Cannabis Debt-to-Revenue Historical Data

The historical data trend for Bedrocan Cannabis's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bedrocan Cannabis Debt-to-Revenue Chart

Bedrocan Cannabis Annual Data
Trend Jan13 Jan14 Jan15
Debt-to-Revenue
N/A N/A N/A

Bedrocan Cannabis Quarterly Data
Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only N/A - - N/A 1.13

Competitive Comparison of Bedrocan Cannabis's Debt-to-Revenue

For the Biotechnology subindustry, Bedrocan Cannabis's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bedrocan Cannabis's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bedrocan Cannabis's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bedrocan Cannabis's Debt-to-Revenue falls into.



Bedrocan Cannabis Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Bedrocan Cannabis's Debt-to-Revenue for the fiscal year that ended in Jan. 2015 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 1.047) / N/A
=N/A

Bedrocan Cannabis's annualized Debt-to-Revenue for the quarter that ended in Apr. 2015 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.099 + 1.391) / 1.32
=1.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Apr. 2015) Revenue data.


Bedrocan Cannabis Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bedrocan Cannabis's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bedrocan Cannabis (FRA:8BC) Business Description

Traded in Other Exchanges
N/A
Address
POCML 2 Inc is a capital pool company. The Company will not carry on any business other than the identification and evaluation of assets or businesses with a view to completing a proposed Qualifying Transaction.

Bedrocan Cannabis (FRA:8BC) Headlines

No Headlines